Biography

J. Dawn Abbott, M.D., is the Director of the Interventional Cardiology Fellowship Training Program at Brown and an interventional cardiologist at Rhode Island Hospital. Her clinical research focuses on percutaneous coronary intervention and peripheral arterial disease. She is a Co-Investigator on the NIH-Sponsored MINT Trial, a grant that is funding a pilot trial to evaluate the role of transfusion therapy in patients with symptomatic coronary artery disease. She is the Site-Principal Investigator at Rhode Island Hospital for several NIH funded studies (Dynamic Registry of Percutaneous Coronary Intervention, PACE-MI, BARI 2D) as well as multicenter investigator initiated and industry funded trials. She has examined the importance of several factors such as stent selection (drug-eluting versus bare metal), gender, and antiplatelet therapy on outcomes in percutaneous intervention. Current actively enrolling trials include the SAFE-PCI trial examining radial versus femoral access for coronary intervention in women, the Tryton study of a novel stent system for the treatment of bifurcation lesions, and the BOSS study examining prevention of contrast induced nephropathy.

Institutions

RIH

Affiliations

Fellow of the American College of Cardiology
American Heart Association, Member of the Council on Cardiovascular Radiology and Intervention
Fellow of the Society of Coronary Angiography and Interventions

Funded Research

American College of Cardiology Foundation (ACCF) Career Development Award in Acute Coronary Syndromes (07/05-06/06)

The Rhode Island Foundation: Medical Research Grant Award (2/07-1/08)

1RC2HL101458-01 NIH/NHLBI, Carson (PI), 2009-2011. Application Title: Transfusion Trigger Trial in Coronary Artery Disease: A Pilot Study. Project Period: 9/30/2009 – 9/29/2011. Role: Co-investigator

Selected Publications

• Grogan M, Jenkins M, Sansing VV, MacGregor J, Brooks MM, Julien-Williams P, Amendola A, Abbott JD for the BARI 2D Study Group. Health Insurance Status and Control of Diabetes and Coronary Artery Disease Risk Factors on Enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Diabetes Educator. 2010 Volume 36(5), 774-83.(2010)
• Baldwin DE, Abbott JD, Trost JC, Vlachos H, Selzer F, Glaser R, Wilensky RL, Slater JN, Doucet S, Naidu SS, Aronow HD, Williams DO A Comparison of Drug-eluting and Bare Metal Stents for Saphenous Vein Graft Lesions: A Report from the National Heart, Lung, and Blood Institute Dynamic Registry. Am J Cardiol 2010 106(7): 946-951.(2010)
• Kim LJ, King SB, Kent K, Kip KE, Brooks MM, Jacobs AK, Rihal C, Abbott JD, Hueb WA, Alderman E, Pena Sing IR, Attubato MJ, Feit F, for the BARI 2D Investigators. Factors Related to the Selection of Surgical versus Percutaneous Revascularization in Diabetic Patients with Multivessel Disease in the BARI 2D Trial. JACC:CI, 2009;2:384-92.(2009)
• Wolf WM, Vlachos HA, Marroquin OC, Lee JS, Smith C, Anderson WD, Schindler JT, MD, Holper EM, Abbott JD, Williams DO, Laskey WK, Kip KE, Kelsey SF, Mulukutla SR. Paclitaxel-Eluting versus Sirolimus-Eluting Stents in Diabetes Mellitus: A Report from the NHLBI Dynamic Registry Circ Cardiovasc Interv. 2010;3:42-49.(2009)
• Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. A Comparison of Bare Metal and Drug-Eluting Stents for Off-Label Indications: Findings from The NHLBI Dynamic Registry. N Engl J Med, 2008; 358: 342-352.(2008)
• Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey W, Williams DO, Smith C., Anderson WD, MD; Lee JS, Srinivas V, Kelsey SF, Kip KE. Drug-Eluting Stents Have Attenuated Benefit Among Insulin-Treated Diabetic Patients A Report from the NHLBI Dynamic Registry. J Am Coll Cardiol: CI, 2008;1;139-147.(2008)
• Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO. Unrestricted Use of Drug Eluting Stents Compared to Bare Metal Stents in Routine Clinical Practice: Findings from the NHLBI Dynamic Registry. J Am Coll Cardiol 2007;50, 2029-2036.(2007)
• Abbott JD, Sharaf BL, Vlachos H, Selzer F, Holper E, Glaser R, Jacobs A, and Williams DO. Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 2007; 99:626-631.(2007)
• Abbott JD, Ahmed HN, Vlachos HA, Selzer F, and Williams DO. Comparison of Outcome in Patients with ST-Elevation-vs-Non ST-Elevation Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention (From the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 2007;100:190-195.(2007)